Gujarat Themis Biosyn Limited — Others, 28-06-2025: Disclosure under SEBI Takeover Regulations

Dr. Dinesh S. Patel and the promoter group of Gujarat Themis Biosyn Ltd. have confirmed no encumbrance on their shareholding during the financial year ended March 31, 2025. Previously disclosed pledging by Pharmaceutical Business Group (India) Ltd in 2023-24 remains unchanged. This clarity on pledge status reduces concerns over share dilution risks and underscores promoter confidence, supporting stakeholder trust in the company’s ownership stability.